Olopatadine
Back to searchMolecule Structure
Scientific Name
Olopatadine
Description of the Drug
Olopatadine is a histamine H1 antagonist used to treat allergic conjunctivitis and rhinitis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00768
http://www.drugbank.ca/drugs/DB00768
Brand Name(s)
Opatanol
Company Owner(s)
Cipla Ltd, Watson Laboratories Inc, Novartis Pharmaceuticals Corp, Amneal Pharmaceuticals Llc, Akorn Operating Co Llc, Rising Pharma Holdings Inc, Alcon Laboratories Inc, Bausch And Lomb Inc, Somerset Therapeutics Llc, Alembic Pharmaceuticals Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Histamine H1 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL231 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL4668 | |||||
| PharmGKB | PA450698 | |||||
| Human Metabolome Database | HMDB0014906 | |||||
| DrugBank | DB00768 | |||||
| PubChem: Thomson Pharma | 14851325 | |||||
| PubChem | 25271818 | 5281071 | ||||
| Mcule | MCULE-1089714662 | |||||
| LINCS | LSM-43199 | |||||
| Nikkaji | J485.528K | |||||
| BindingDB | 50002096 | |||||
| EPA CompTox Dashboard | DTXSID3023390 | |||||
| DrugCentral | 1986 | |||||
| Brenda | 144773 | |||||
| ChemicalBook | CB0689142 | |||||
| Guide to Pharmacology | 7249 | |||||
| rxnorm | PATANOL | PAZEO | OLOPATADINE | OLOPATADINE HYDROCHLORIDE | PATADAY | PATANASE |
| ZINC | ZINC000000001850 |
